SCHEMBL17275758

SCHEMBL17275758

CN1C(=O)C(C)(C)c2ccc(C(=O)NNC(=O)c3ccncc3)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ TP53 P04637 1/20 0.46
▸ KMT2A Q03164 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ TSHR P16473 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CA1 P00915 2/20 0.40
▸ CA9 Q16790 2/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GAA P10253 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CRHBP P24387 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16324955 0.86 TP53 (0.39) TP53KDM4EMAPTGAASMN1; SMN2
SCHEMBL17275671 0.85 ALDH1A1 (0.49) ALDH1A1TP53KMT2AKDM4EMAPT
SCHEMBL15579146 0.84 GAA (0.50) TP53KDM4EMAPTHTTHSD17B10
SCHEMBL17275862 0.80 MYC (0.44) ALDH1A1TP53KDM4EMAPTCA1
SCHEMBL18549334 0.80 ALDH1A1 (0.40) ALDH1A1TP53KMT2AKDM4EHTT
SCHEMBL20686145 0.79 ALDH1A1 (0.38) ALDH1A1TP53KMT2AKDM4EMAPT
SCHEMBL15578937 0.78 WNT1 (0.47) ALDH1A1TP53KMT2AKDM4EMAPT
SCHEMBL17275664 0.78 STING1 (0.37) TP53SMN1; SMN2POLBLMNACRHR2
SCHEMBL9201147 0.77 MAPT (0.43) TP53KMT2AKDM4EMAPTHTT
SCHEMBL9142318 0.77 LMNA (0.46) HSD17B10GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385050-B2 Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives HOFFMANN-LA ROCHE INC. (US) 2019-08-20 — — US disclosed
EP-3145923-B1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-C]PYRIDIN-2-ONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2019-01-30 — — EP disclosed
US-20190016719-A1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2019-01-17 — — US disclosed
US-10112938-B2 Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives HOFFMAN-LA ROCHE INC. (US) 2018-10-30 — — US disclosed
EP-3145923-A1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2017-03-29 — — EP disclosed
US-20170057960-A1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2017-03-02 — — US disclosed
WO-2015177110-A1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2015-11-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10385050-B2 Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives TPH1, TPH2, HTR1A ALDH1A1 437/4885TP53 3618/4885KMT2A 3009/4885
US-20190016719-A1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES TPH1, TPH2, HTR1A ALDH1A1 437/4885TP53 3618/4885KMT2A 3009/4885
US-20170057960-A1 INDOLIN-2-ONE AND 1,3-DIHYDRO-PYRROLO[3,2-c]PYRIDIN-2-ONE DERIVATIVES TPH1, TPH2, HTR1A ALDH1A1 437/4885TP53 3618/4885KMT2A 3009/4885
US-10112938-B2 Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives TPH1, TPH2, HTR1A ALDH1A1 437/4885TP53 3618/4885KMT2A 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback